for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Genomma Lab Internacional SAB de CV

LABB.MX

Latest Trade

19.47MXN

Change

0.42(+2.20%)

Volume

1,317,600

Today's Range

18.98

 - 

19.47

52 Week Range

11.10

 - 

19.47

As of on the Mexico Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
19.05
Open
18.98
Volume
1,317,600
3M AVG Volume
38.66
Today's High
19.47
Today's Low
18.98
52 Week High
19.47
52 Week Low
11.10
Shares Out (MIL)
1,013.43
Market Cap (MIL)
19,377.52
Forward P/E
16.50
Dividend (Yield %)
--

Next Event

Q3 2019 Genomma Lab Internacional SAB de CV Earnings Release

Latest Developments

More

Genomma Lab Internacional appoints new executive vice president and CFO

HR Ratings affirms rating for Genomma Lab Internacional SAB de CV

Genomma Lab Internacional SAB de CV sells Grupo Marzam for 2.93 bln pesos

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Genomma Lab Internacional SAB de CV

Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The Company is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Industry

Biotechnology & Drugs

Contact Info

Edificio Samara

Antonio Dovali Jaime no. 70 Piso 2

Colonia Santa Fe

+52.55.50810000

http://www.genommalab.com/mx/

Executive Leadership

Rodrigo Alonso Herrera Aspra

Chairman of the Board, Independent Director

Maximo Juda

Chief Executive Officer

Antonio Zamora Galland

Executive Vice President, Chief Financial and Chief Administrative Officer

Marco Sparvieri

Executive Vice-President of Global Sales

Alejandro Baston Patino

Vice-President of International and Sales Development

Key Stats

2.92 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, MXN)

2016

11.6K

2017

12.1K

2018

12.3K

2019(E)

12.8K
EPS (MXN)

2016

1.347

2017

1.340

2018

1.190

2019(E)

1.118
Price To Earnings (TTM)
20.84
Price To Sales (TTM)
1.60
Price To Book (MRQ)
2.37
Price To Cash Flow (TTM)
18.73
Total Debt To Equity (MRQ)
77.26
LT Debt To Equity (MRQ)
49.76
Return on Investment (TTM)
7.08
Return on Equity (TTM)
5.13

Latest News

Latest News

EMERGING MARKETS-Latam markets sink, reform worries grip Brazil markets

(Recasts throughout, updates prices) * Brazil currency dives almost 3 percent, stocks down 3.6 percent * Argentina peso hits fresh all-time low vs dollar * Mexican shares buck gloom, rise 0.3 percent By Susan Mathew March 27 (Reuters) - Latin American shares and currencies...

Banco de Bajio and Genomma Lab to enter main Mexican stock index

S&P Dow Jones Indices (S&P DJI) said on Friday that shares in bank Banco del Bajio and pharmaceutical company Genomma Lab would enter Mexico's leading share index from Sept. 24.

GMexico rail unit added to Mexican stock index, Genomma Lab exits

GMexico Transportes , the rail unit of Mexican miner and infrastructure company Grupo Mexico, will be added to the country's benchmark S&P/BMV IPC stock index starting on March 20, S&P Dow Jones Indices said on Friday.

Nexxus Capital fund to invest $350 mln in Mexico, Spain, Portugal

Private equity fund Nexxus Capital said on Monday it plans to invest $350 million over 12 to 18 months in small- and medium-sized firms with high exposure to middle-class consumers in Mexico, Spain and Portugal.

Mexican companies slash debt as peso rallies

Many Mexican companies, from dominant telecom provider America Movil to bottler Femsa, cut debts in the second quarter, helped by a stronger peso, although they are unlikely to rush to return money to investors or increase investment.

EMERGING MARKETS-Brazil stock market up, Mexico finds ground after slump

Brazilian stocks rose on Tuesday, lifted by corporate news and quarterly reports, while Mexican stocks bounced back from a four-day slump after earnings reports disappointed some investors. Mexico's S&P/BMV IPC stock index ticked up 0.36 percent to 51,195 points. The index...

Mexico competition watchdog opens probe into market for medicines

Mexico's competition regulator Cofece said on Wednesday it had opened an investigation into possible "absolute monopolistic practices" in the country's medicines market.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up